19.79USD-4.99%Mkt Cap: 1.09B USDP/E: —Last update: 2026-06-01
Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company's lead product candi…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.09B USD
Enterprise Value619.55M USD
Revenue (TTM)8.28M USD
Gross Profit-63.35M USD
Net Income (TTM)-63.73M USD
Revenue/Share0.6480 USD
Last Price19.79 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees79
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.55
PEG—
EV/EBITDA-8.07
EV/Revenue74.85
P/S138.51
P/B2.27
EPS (TTM)-1.21
EPS (Forward)-2.17
52W Range
14.7235% of range29.16
52W High29.16 USD
52W Low14.72 USD
Profitability
Gross Margin0.00%
Oper. Margin-703.63%
EBITDA Margin0.00%
Profit Margin-980.93%
ROE43.61%
ROA-24.06%
Growth
Revenue Growth123.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-64.13M USD
CapEx (TTM)9.58M USD
FCF Margin—
FCF Yield—
Net Debt-526.91M USD
Net Debt/EBITDA6.87
Balance Sheet
Debt/Equity-0.08
Current Ratio19.49
Quick Ratio19.37
Book Value/Sh9.156 USD
Cash/Share9.741 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)32.25 USD
Target Range30.00 USD – 34.00 USD
# Analysts5
Ownership
Shares Out.53.40M
Float28.15M
Insiders14.14%
Institutions74.22%
Short Interest
Short Ratio12.4d
Short % Float15.97%
Short % Out.4.57%
Shares Short2.53M
Short (prev mo.)2.34M
Technical
SMA 5018.78 (+5.4%)
SMA 20019.27 (+2.7%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)171.83K
Avg Vol (10d)143.15K
Technical Indicators
RSI (14)60.3
MACD0.3398
MACD Signal0.1910
MACD Hist.+0.1488
BB Upper20.91 USD
BB Middle19.46 USD
BB Lower18.02 USD
BB Width14.87%
ATR (14)1.136 USD
Vol Ratio (20d)0.52x